CD20-directed Cytolytic Antibody



Ofatumumab Pen Injector

0.4 ML ofatumumab 50 MG/ML Pen InjectorGeneric
0.4 ML ofatumumab 50 MG/ML Pen Injector [Kesimpta]Generic

Ofatumumab drug classes:

  • CD20-directed Cytolytic Antibody

Ofatumumab pharmacologic actions:

  • Antineoplastic Agents

Ofatumumab mechanism of action:

  • CD20-directed Antibody Interactions
  • treatable

The content offered on Treatable.org is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

LegitScript approved
Copyright © Treatable 2023
Last updated: 1/30/2024, 12:28:23 PM